Clinical trials
Uveitis clinical trials
Below are recruiting uveitis clinical trials, each written for real people, not researchers. We’re tracking 24 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05486468RecruitingPhase 3
Two YUTIQ injections versus sham for chronic eye inflammation
This study tests whether receiving two YUTIQ injections works better than a sham (fake) treatment for long-lasting inflammation inside the back part of the eye. It is meant to reduce ongoing “posterior segment” inflammation and improve comfort and eye health when prior steroid treatments have helped but the inflammation keeps coming back.
Plano, TexasAges 18 years+ - NCT02357238Recruiting
Study of genetics in people with uveitis
This study looks at genetic (inherited) differences in people with uveitis. The goal is to better understand what may cause uveitis and potentially help with future treatments.
Cleveland, OhioAges 6 years+ - NCT02706704RecruitingPhase 2
Adalimumab eye injections vs under-skin shots for uveitis
This trial compares two forms of the same medicine (adalimumab) to treat non-infectious uveitis, an inflammation inside the eye. It aims to see which delivery method works better to control active inflammation and protect vision.
BeirutAges 18 years+ - NCT07285070RecruitingPhase 2
Tacrolimus eye drops for non-infectious anterior uveitis
This trial tests a new eye drop (tacrolimus) to treat non-infectious anterior uveitis, an inflammation in the front part of the eye. It may help reduce the need for steroid eye drops.
Phoenix, ArizonaAges 18 years+ - NCT06539481RecruitingPhase 4
ILUVIEN eye implant for kids with recurrent eye inflammation
This trial tests an eye implant (ILUVIEN) in children and teens ages 6 to 17 who have a type of eye inflammation called uveitis that keeps coming back. The implant releases medicine slowly over time to control inflammation and may help reduce the need for other treatments.
BerlinAges 6–17 - NCT07547995RecruitingPhase 2
A study of a new drug for active uveitis
This study tests a new drug (GenSci048) for people with active, non-infectious uveitis in the middle or back of the eye, who are already taking oral steroids. The goal is to see if the drug can better control inflammation and reduce the need for steroids.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05388838Recruiting
Screening for a rare lymphoma type in eye inflammation patients
This trial screens people with certain eye inflammation (uveitis) to see if they might have a specific rare lymphoma linked to immune cells. It may help doctors identify the right diagnosis and understand which patients need closer monitoring.
LyonAges 18 years+ - NCT05474729RecruitingPhase 1/Phase 2
Minocycline for chronic autoimmune eye inflammation
This trial tests whether minocycline, an antibiotic that can also reduce inflammation, helps improve chronic autoimmune uveitis and protect vision. It may help by lowering ongoing immune irritation that damages the eye.
Guangzhou, GuangdongAges 18–70 - NCT05592717Recruiting
YUTIQ implant for chronic non-infectious eye inflammation
This trial tests whether a small steroid implant placed inside the eye (YUTIQ 0.18 mg) can control chronic non-infectious uveitis. It may help reduce active inflammation and prevent flare-ups, as long as you’ve had recent signs of active disease and can follow the medication and eye-visit rules.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT05727540Recruiting
Cohort study of people with uveitis
This study follows people who have been diagnosed with uveitis (inflammation inside the eye). It helps researchers better understand the condition and how people do over time.
Guangzhou, GuangdongAges 18–90 - NCT06273748Recruiting
Study on chronic eye inflammation in children
This study looks at children with long-term eye inflammation that is not caused by an infection. It aims to learn more about the condition and how to better help patients.
Kansas City, KansasAges 1–16 - NCT06720376Recruiting
Uveitis and arthritis study for Turkish patients
This study follows people with uveitis (eye inflammation) to learn more about how it relates to spondyloarthritis (arthritis of the spine). You may be able to join if you have uveitis, but not if you already had spondyloarthritis before your uveitis started or if your uveitis is caused by an infection.
Istanbul, MaltepeAges 18–75 - NCT07065747Recruiting
Understanding inflammation in uveitis using advanced eye imaging
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
Portland, OregonAges 5–85 - NCT07145008RecruitingEarly Phase 1
Suprachoroidal steroid injection for uveitis-related macular edema
This trial tests a different way of giving a steroid injection for eye swelling (macular edema) caused by uveitis. It is for people whose swelling hasn't improved with a standard steroid injection behind the eye.
BaghdadAges 18 years+ - NCT07518134Recruiting
Understanding Uveitis in Children Under 18
This study looks at uveitis, a type of eye inflammation, in children. Researchers want to learn more about different types of uveitis and how they affect children, whether the inflammation is new or has been going on for a while.
Boston, MassachusettsAges Up to 17 years - NCT07663331RecruitingPhase 4
Adalimumab for adults with non-infectious uveitis
This study tests an injection called adalimumab (Tebiovio®) to see if it helps control inflammation in the eyes of adults with non-infectious uveitis. It might be a good option if you are already on steroid pills and looking for another treatment.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT04521673Recruiting
Detecting causes of infectious eye inflammation
This trial looks for germs causing eye inflammation (uveitis) that may be due to an infection. It could help identify the best treatment for your condition.
ShanghaiAges Any age - NCT06974162Recruiting
Decoding eye inflammation with genetic sequencing
This trial uses a new genetic test to find the cause of eye inflammation when standard tests haven't. The goal is to see if this approach can identify hidden infections and help doctors choose the right treatment to protect your vision.
LondonAges Any age - NCT05153057Recruiting
Follow-up study for birdshot eye inflammation
This study follows people with “birdshot chorioretinopathy,” a rare eye inflammation, and collects immune (genetic) information to better understand the disease. You may benefit from closer monitoring, and the results may help guide future treatments.
Paris, Île-de-France RegionAges 18 years+ - NCT05200715Recruiting
Registry study for inherited and inflammatory eye and joint diseases
This study is a registry, meaning it collects your medical information to better understand several inflammatory (auto-inflammatory) conditions. It may help doctors and researchers improve diagnosis and future treatments for people with these disorders.
AlgiersAges Any age - NCT06161415RecruitingPhase 1
Laquinimod eye drops before vitrectomy: safety study
This trial tests a new eye drop called Laquinimod for people who are already scheduled for a vitrectomy. The drops are given before surgery to see if they are safe and how they spread in the eye.
Palo Alto, CaliforniaAges 18 years+ - NCT01277419Recruiting
Study of new cases of several spine, joint, and eye diseases
This study enrolls people who have recently been diagnosed with certain inflammatory conditions affecting the spine, joints, or the eye. Researchers are looking to better understand how these illnesses start and how they may be linked, which could help guide future care.
BerlinAges Any age - NCT01746537Recruiting
Eye imaging test in people with uveitis
This study uses a special eye scan (optical coherence tomography) to look at inflammation in the front part of the eye. It may help doctors better measure uveitis activity and guide care by improving how inflammation is seen on scans.
Cleveland, OhioAges Any age - NCT07552012RecruitingPhase 2
FXS5626 for Non-Infectious Eye Inflammation
This trial tests a new drug called FXS5626 to treat non-infectious uveitis—inflammation inside the eye that doesn't come from infection. The study looks at whether this drug can reduce eye inflammation and improve vision in people whose condition isn't controlled with steroid eye drops and oral steroids alone.
Chongqing, Chongqing MunicipalityAges 18–70
Hear when a new Uveitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Uveitis trials by city
Studies with a site in or near these metro areas.
Uveitis trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for uveitis?
- Yes. Clin2 currently lists 24 recruiting uveitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a uveitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a uveitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.